Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases.
- DOI
- 10.1021/acs.jmedchem.6c00667
- Published
- 2026 Aug 13
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00667,
title = {Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases.},
author = {Zhang Z and Wang X and Luo X and Li C and Liu Z and Xia C and Yu L and Chen X and Sun Y and Wang P and Gao L and Cao X and Zhang Y and Wang Y and Liu H and Sun Y and Zhou S and Li J and Zhou Y},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c00667},
url = {https://doi.org/10.1021/acs.jmedchem.6c00667}
}RIS
TY - JOUR TI - Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases. AU - Zhang Z AU - Wang X AU - Luo X AU - Li C AU - Liu Z AU - Xia C AU - Yu L AU - Chen X AU - Sun Y AU - Wang P AU - Gao L AU - Cao X AU - Zhang Y AU - Wang Y AU - Liu H AU - Sun Y AU - Zhou S AU - Li J AU - Zhou Y PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c00667 UR - https://doi.org/10.1021/acs.jmedchem.6c00667 ER -
APA
Z, Z., X, W., X, L., C, L., Z, L., C, X., L, Y., X, C., Y, S., P, W., L, G., X, C., Y, Z., Y, W., H, L., Y, S., S, Z., J, L., & Y, Z. (2026). Structure-Based Drug Design of Novel Indazole/Indolinone-Based Biaryl Derivatives as Oral IRAK4 Inhibitors for the Treatment of Inflammatory Diseases.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00667
Source records
- pubmed · retrieved 2026-11-10T17:58:11.692Z